Literature DB >> 16012128

Animal models for acquired bone marrow failure syndromes.

Jichun Chen1.   

Abstract

Bone marrow failure is a disease characterized by a drastic decline in the marrow's functional ability to produce mature blood cells. Aplastic anemia, a disease in which patients have essentially empty bone marrow accompanied by severe anemia, neutropenia, and thrombocytopenia, presents a paradigm for bone marrow failure. Damage to the marrow may first result from exposure to toxic chemicals, drug overdose, radiation, and viral infection; however, it is the extended immune-mediated reaction that causes massive destruction of hematopoietic cells and leads to marrow hypoplasia and peripheral pancytopenia. In recent years, animal models of acquired bone marrow failure syndromes have helped to strengthen our understanding of the mechanisms causing bone marrow failure. In this review, animal models for bone marrow failure are summarized by two groups: 1) bone marrow failure induced by toxic chemicals and drugs such as benzene, busulfan, and chloramphenicol, and radiation, and 2) models developed by an immune-related mechanism such as viral infection or foreign lymphocyte infusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012128      PMCID: PMC1183440          DOI: 10.3121/cmr.3.2.102

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  55 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.

Authors:  Hiroki Yamaguchi; Rodrigo T Calado; Hinh Ly; Sachiko Kajigaya; Gabriela M Baerlocher; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

3.  Aplastic anaemia in sublethally irradiated mice given allogeneic lymph node cells.

Authors:  D W Barnes; R H Mole
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

4.  An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.

Authors:  A Morley; J Blake
Journal:  Blood       Date:  1974-07       Impact factor: 22.113

5.  Studies on the haemotoxicity of chloramphenicol succinate in the Dunkin Hartley guinea pig.

Authors:  J A Turton; C M Andrews; A C Havard; T C Williams
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

6.  In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.

Authors:  Antonio M Risitano; Jaroslaw P Maciejewski; Spencer Green; Magdalena Plasilova; Weihua Zeng; Neal S Young
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

7.  Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells.

Authors:  Aimin Meng; Yong Wang; Gary Van Zant; Daohong Zhou
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  Exposure of hematopoietic stem cells to benzene or 1,4-benzoquinone induces gender-specific gene expression.

Authors:  Brenda Faiola; Elizabeth S Fuller; Victoria A Wong; Linda Pluta; Diane J Abernethy; Jason Rose; Leslie Recio
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 9.  Parvovirus B19 and the pathogenesis of anaemia.

Authors:  Hiroshi Chisaka; Eiji Morita; Nobuo Yaegashi; Kazuo Sugamura
Journal:  Rev Med Virol       Date:  2003 Nov-Dec       Impact factor: 6.989

10.  Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure.

Authors:  Jichun Chen; Karen Lipovsky; Felicia M Ellison; Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2004-05-27       Impact factor: 22.113

View more
  22 in total

1.  New challenges to developing animal models for human immune-mediated marrow failure.

Authors:  Antonio M Risitano
Journal:  Clin Med Res       Date:  2005-05

2.  An animal model of chronic aplastic bone marrow failure following pesticide exposure in mice.

Authors:  Sumanta Chatterjee; Malay Chaklader; Pratima Basak; Prosun Das; Madhurima Das; Jacintha Archana Pereira; Ranjan Kumar Dutta; Samaresh Chaudhuri; Sujata Law
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

Review 3.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Rapamycin targets several pathophysiological features of immune-mediated bone marrow failure in murine models.

Authors:  Wendy W Weston; Vesna Jurecic; Roland Jurecic
Journal:  Haematologica       Date:  2017-10       Impact factor: 9.941

5.  Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγ(null) (NSG) mice conditioned by busulfan.

Authors:  Bongkum Choi; Eunyoung Chun; Miyoung Kim; Seong-Tae Kim; Keejung Yoon; Ki-Young Lee; Sung Joo Kim
Journal:  J Clin Immunol       Date:  2010-10-28       Impact factor: 8.317

6.  Immune-mediated bone marrow failure in C57BL/6 mice.

Authors:  Jichun Chen; Marie J Desierto; Xingmin Feng; Angélique Biancotto; Neal S Young
Journal:  Exp Hematol       Date:  2014-12-30       Impact factor: 3.084

Review 7.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

8.  Role of perforin-mediated cell apoptosis in murine models of infusion-induced bone marrow failure.

Authors:  Annahita K Sarcon; Marie J Desierto; Wenjun Zhou; Valeria Visconte; Federica Gibellini; Jichun Chen; Neal S Young
Journal:  Exp Hematol       Date:  2009-02-12       Impact factor: 3.084

9.  Telomere dysfunction in human diseases: the long and short of it!

Authors:  Kathryn A Carroll; Hinh Ly
Journal:  Int J Clin Exp Pathol       Date:  2009-05-10

10.  Genetic and environmental factors influencing human diseases with telomere dysfunction.

Authors:  Hinh Ly
Journal:  Int J Clin Exp Med       Date:  2009-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.